NCT03790696

Brief Summary

The first aim of this study, as mentioned in the attached NIH grant, is to test the feasibility and acceptability of a novel computer-based cognitive training program that is designed to rehabilitate the brain's ventral attention network (VAN), a brain system associated with anxiety disorders. Once feasibility and acceptability is determined the investigators will begin aim 2 where the investigators will test the efficacy of this novel treatment, which could reduce the symptoms of anxiety disorders in children (and adults) by training them to actively ignore stimuli in turn reducing the activity of the VAN. To test this potential treatment the investigators will recruit 60 children with anxiety disorders and 10 healthy children to compare an active version of a computer training program to a sham version of training. The investigators will also measure VAN reactivity before and after treatment using functional magnetic resonance imaging (fMRI). The rationale of this research is that it could lead to a novel, safe, mechanism-based treatment for a major public health problem.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 2, 2017

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

December 18, 2018

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 2, 2019

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2020

Completed
5.1 years until next milestone

Results Posted

Study results publicly available

April 27, 2025

Completed
Last Updated

April 27, 2025

Status Verified

April 1, 2025

Enrollment Period

3.2 years

First QC Date

December 18, 2018

Results QC Date

November 16, 2022

Last Update Submit

April 23, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Symptoms of Anxiety Based on Screen for Anxiety and Related Disorders (SCARED) Parent Report at Baseline and Post Assessment

    Another outcome will be change in symptoms of anxiety as measured by the SCARED at the baseline and post training assessments. These scores will be subtracted (post training assessment - baseline assessment) to see the change in anxiety symptoms from the beginning of the study to post treatment. A total score of \>25 may indicate the presence of an Anxiety Disorder. Scores higher than 40 are more specific based on the total score for specific items. Scores for the SCARED can range from 0-82.

    Children/Caregivers will complete the SCARED measure at their baseline appointment before beginning treatment as well as at their final appointment after 4 weeks of completing the training.

Secondary Outcomes (2)

  • Change in Symptoms of Anxiety Based on Screen for Anxiety and Related Disorders (SCARED) Child Report at Baseline and Post Assessment

    Children/Caregivers will complete the SCARED measure at their baseline appointment before beginning treatment as well as at their final appointment after 4 weeks of completing the training.

  • Change in Symptoms of Anxiety Based on Pediatric Anxiety Rating Scale (PARS) From Baseline to Post Assessment.

    The PARS measure will be collected at the baseline appointment before subjects begin the cognitive training as well as after completing 8 cognitive training sessions in four weeks.

Study Arms (2)

Active Cognitive Training

EXPERIMENTAL

Participants will complete 30-45 minute cognitive training program twice a week for four weeks.

Device: Cognitive Training Program

Sham Cognitive Training

SHAM COMPARATOR

Participants will complete 30-45 minute cognitive training program twice a week for four weeks.

Device: Cognitive Training Program

Interventions

The cognitive training program has been designed by Dr. Sylvester. It is a simple computer game looking at some shapes and faces on a computer screen and pressing a button when a target shape appears. This is the first study to use this exact computer training regimen for testing in its ability to reduce symptoms of anxiety in children with anxiety disorders. Each session of the computer game takes approximately 45-60 minutes and subjects complete 8 total sessions over one month. The computer game involves paying attention to parts of the screen while distracting square boxes appear at other locations. A target "X" appears at the location that participants are paying attention to and the subjects press a button when it appears.

Also known as: novel computer-based cognitive training program, computer-delivered cognitive training program
Active Cognitive TrainingSham Cognitive Training

Eligibility Criteria

Age8 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • ages of 8-12
  • have a current diagnosis of separation anxiety disorder, generalized anxiety disorder, and/or social phobia.

You may not qualify if:

  • prior diagnoses of attention deficit hyperactivity disorder (ADHD)
  • autism spectrum disorder
  • intellectual disability (IQ\<70)
  • a significant medical problem
  • current use of psychotropic medication other than selective serotonin reuptake inhibitor (SSRI) (children who are currently taking an SSRI and are still experiencing symptoms of anxiety will not be excluded).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Washinton University School of Medicine

St Louis, Missouri, 63108, United States

Location

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Limitations and Caveats

An important limitation of the present study is that there was no control group without any cognitive training and the sample size was small. Therefore, we cannot conclusively state that the task itself reduced anxiety as opposed to non-specific factors.

Results Point of Contact

Title
Jennifer Harper / Clinical Research Coordinator
Organization
Washington University School of Medicine

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Subjects will be randomized to active vs. sham treatment on a 50/50 basis. The participants and the staff performing the pre- and post- treatment psychiatric interviews will remain blinded throughout the study. Study staff administering the treatment will be aware of the active vs. sham status of the participant, in order to deliver and monitor the appropriate cognitive training program.
Purpose
TREATMENT
Intervention Model
FACTORIAL
Model Details: This study is a randomized control trial.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 18, 2018

First Posted

January 2, 2019

Study Start

February 2, 2017

Primary Completion

March 31, 2020

Study Completion

March 31, 2020

Last Updated

April 27, 2025

Results First Posted

April 27, 2025

Record last verified: 2025-04

Locations